Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Clinical trial NCT01815073 · COMPLETED

Trial details

NCT number: NCT01815073
Sponsor: Changchun Keygen Biological Products Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Japanese Encephalitis Chickenpox

Start date: 2013-03-01
Primary completion: 2013-07-01
Enrollment: 497

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.